α- Versus β-Emitting Radionuclides for Pretargeted Radioimmunotherapy of Carcinoembryonic Antigen-Expressing Human Colon Cancer Xenografts.

about

Aligning physics and physiology: Engineering antibodies for radionuclide delivery.Chemically triggered drug release from an antibody-drug conjugate leads to potent antitumour activity in mice.

P2860

Q51740406-1809BBA9-BB89-4533-88E7-2018606753F0 Q55040576-0D6A94D8-4517-4EE4-99EB-256F4B9F4A99

P2860

α- Versus β-Emitting Radionuclides for Pretargeted Radioimmunotherapy of Carcinoembryonic Antigen-Expressing Human Colon Cancer Xenografts.

Item

http://www.wikidata.org/entity/Q38715106

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

α- Versus β-Emitting Radionucl ...... Human Colon Cancer Xenografts.

@en

type

Item

label

α- Versus β-Emitting Radionucl ...... Human Colon Cancer Xenografts.

@en

prefLabel

α- Versus β-Emitting Radionucl ...... Human Colon Cancer Xenografts.

@en

P1476

α- Versus β-Emitting Radionucl ...... Human Colon Cancer Xenografts.

@en

P2093

Alfred Morgenstern

http://www.w3.org/2001/XMLSchema#string

Christof Seidl

http://www.w3.org/2001/XMLSchema#string

David M Goldenberg

http://www.w3.org/2001/XMLSchema#string

Erik J Steenbergen

http://www.w3.org/2001/XMLSchema#string

Frank Bruchertseifer

http://www.w3.org/2001/XMLSchema#string

Janneke D M Molkenboer-Kuenen

http://www.w3.org/2001/XMLSchema#string

Markus Essler

http://www.w3.org/2001/XMLSchema#string

Reinier Hernandez

http://www.w3.org/2001/XMLSchema#string

Sandra Heskamp

http://www.w3.org/2001/XMLSchema#string

Weibo Cai

http://www.w3.org/2001/XMLSchema#string

P2860

Alpha-particle emitting 213Bi-anti-EGFR immunoconjugates eradicate tumor cells independent of oxygenation

Anti-CD45 pretargeted radioimmunotherapy using bismuth-213: high rates of complete remission and long-term survival in a mouse myeloid leukemia xenograft model

Antibody-targeted radiation cancer therapy

Phase II trial of carcinoembryonic antigen radioimmunotherapy with 131I-labetuzumab after salvage resection of colorectal metastases in the liver: five-year safety and efficacy results.

Predictive patient-specific dosimetry and individualized dosing of pretargeted radioimmunotherapy in patients with advanced colorectal cancer.

Conventional and pretargeted radioimmunotherapy using bismuth-213 to target and treat non-Hodgkin lymphomas expressing CD20: a preclinical model toward optimal consolidation therapy to eradicate minimal residual disease.

Radioimmunotherapy with α-particle-emitting radionuclides.

Stably tethered multifunctional structures of defined composition made by the dock and lock method for use in cancer targeting.

Cancer radioimmunotherapy.

Pretargeted immuno-PET of CEA-expressing intraperitoneal human colonic tumor xenografts: a new sensitive detection method.

P304

926-933

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2967/JNUMED.116.187021

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Otto C. Boerman

P577

2017-02-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28232604

http://www.w3.org/2001/XMLSchema#string

P921

xenograft

P932

5450366

http://www.w3.org/2001/XMLSchema#string

α- Versus β-Emitting Radionuclides for Pretargeted Radioimmunotherapy of Carcinoembryonic Antigen-Expressing Human Colon Cancer Xenografts.

about

P2860

P2860

α- Versus β-Emitting Radionuclides for Pretargeted Radioimmunotherapy of Carcinoembryonic Antigen-Expressing Human Colon Cancer Xenografts.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P932